On Feb 7, 2022 Koneksa Health closed a Series C round and raised $45,000,000 from dRx Capital, Matrix Capital Management, McKesson Ventures, Merck Global Health Innovation Fund, Spring Mountain Capital, Takeda Ventures, Inc., Velosity Capital, Waterline Ventures, featuring lead investors Matrix Capital Management.

About the company: Koneksa Health is located at United States, North America.
“Koneksa Health develops digital biomarkers for use in pharamceutical and biopharmaceutical clinical trials. Contact us today to learn more.”

Company website: http://www.koneksahealth.com